Purpose: Image-guidance to ensure correct patient set-up prior to treatment delivery is of utmost importance in SBRT. Many studies have demonstrated high levels of concordance between radiation therapists (RTs) and radiation oncologists (ROs) on daily verification based on electronic portal imaging and simulator films. There is limited data, however, on the concordance between RTs and ROs using CBCT pre-treatment images prior to SBRT. The primary objective of this study is to evaluate the level of concordance between RTs and ROs on CBCT pre-treatment verification images for SBRT. Methods and Materials: Twenty-one consecutively treated SBRT patients at a provincial institution were included in the study. CBCT was performed by both RO and RTs prior to delivery of each fraction for abdominal and bone SBRT treatments, and prior to first fraction for lung SBRT. RTs performed subsequent daily matches for lung SBRT. Initial CBCT match was performed by RTs as per centre guidelines or by previously specified instructions. ROs performed second match prior to SBRT delivery. Directional differences between RT and RO match were recorded and analyzed. Intraclass correlation coefficients were calculated to determine variability between RT and RO match, with values approaching 1 suggesting high concordance. Results: Thirty-six CBCT images were analyzed. Thirteen were lung, 20 abdominal (five liver, 15 pancreas) and three were bone SBRT cases. RO made adjustments to initial RT match in 12 (33%) of CBCT matches, with six matches having a direction shift of 0.1 to < 0.2 cm in any direction, and two matches with a directional shift of ≥ 0.2 cm. Mean maximum match difference was 0.12 cm (range: 0.02, 0.31 cm). Treatments requiring adjustment to the initial RT match did not differ by treatment site. Review of the two plans with match difference of ≥ 0.2 cm revealed no appreciable change in GTV coverage and with dose to organs at risk still within accepted constraints. Intraclass correlation coefficients for all CBCT matches were 0.998 (95% CI: 0.996-0.999), 0.997 (95% CI: 0.995-0.999), 0.996 (95% CI: 0.992-0.998) in the x, y, and z directions respectively. Intraclass correlation coefficients for CBCT matches that required adjustment by RO were similar at 0.995 (95%CI: 0.982-0.9980.982-0.998), 0.995 (95% CI: 0.984-0.9990.984-0.999), 0.989 (95% CI: 0.962-0.997) in the x, y, and z directions respectively. Conclusions: CBCT match for SBRT at our center shows high concordance between RTs and ROs. These findings support potential expansion of RT scope of practice at our institution to include independent CBCT matches for SBRT. Purpose: Over the course of radiation therapy treatments for head and neck (H&N) cancers, many patients' contours change shape due to weight loss. This affects the fit of the shell, and the shape of the planned dosimetric volumes. There are a variety of methods used to measure the change in a patients' external contour over the course of their treatment. Investigation is needed to determine the effectiveness of these methods. The objective was to complete a retrospective analysis that compares the weekly use of Cone Beam Computed Tomography (CBCT) to a conventional method involving small wooden sticks.
CONE BEAM VERSUS STICK METHOD: A RETROSPECTIVE ANALYSIS COMPARING THE ACCURACY OF CONE BEAM GAP MEASUREMENTS TO CONVENTIONAL STICK MEASUREMENTS FOR HEAD AND NECK PATIENTS UNDERGOING RADIATION THERAPY
Purpose: Over the course of radiation therapy treatments for head and neck (H&N) cancers, many patients' contours change shape due to weight loss. This affects the fit of the shell, and the shape of the planned dosimetric volumes. There are a variety of methods used to measure the change in a patients' external contour over the course of their treatment. Investigation is needed to determine the effectiveness of these methods. The objective was to complete a retrospective analysis that compares the weekly use of Cone Beam Computed Tomography (CBCT) to a conventional method involving small wooden sticks.
These methods assess the change in contour based on the distance of the skin to the immobilization shell. Purpose: In Canada, in 2015 an estimated 25,000 women were diagnosed with breast cancer. For early-breast stage cancer, the recommended treatment is breast conserving surgery followed by radiation therapy. The standard of care is whole-breast irradiation, which requires a treatment time of four to six weeks. Accelerated partial breast irradiation by multi-catheter interstitial brachytherapy is an alternative that is delivered in just one week or less. To achieve ideal dosimetry over the tumour bed, the catheters must be placed parallel with equal spacing in the deformable breast tissue -a technical challenge that requires image guidance. Ultrasound (US) imaging is a safe and affordable guidance modality, but it is difficult to use in the presence of interference between the catheters. We propose using real-time electromagnetic (EMT) navigation to shore up the US-guided catheter insertion process.
Methods and Materials:
A tissue-locking needle and US probe are equipped with EMT. Under US guidance, the needle is inserted and locked in the tumour bed, providing a locally rigid reference. The target volume is segmented in US, yielding a tracked model in a virtual view. An EMT-enabled needle guide is pointed at the target and a catheter needle is inserted through the guide into the tissue. Additional parallel catheters are planned on the virtual view based on the first insertion and implanted in the target. The guidance software is built on the 3D Slicer (www.slicer.org) open source platform. Anthropomorphic plastic phantoms were created, each containing a simulated tumour bed that can be visualized in both US and CT. In our experiment, two rows of five catheter needles per row, for a total of 10 catheters were inserted in two phantoms. The intention was to place each catheter 1 cm apart. The first phantom had catheter needles inserted under sole US guidance to the target and the second under combined EMT-US guidance. Both insertions were performed by the same operator.
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The position of the catheters relative to the tumour bed was measured in CT. Results: With sole US guidance, seven out of 10 catheters passed through the tumour bed. The catheter spacing was inconsistent and the desired goal of two rows of five equally-spaced catheters was not precisely achieved, with a mean spacing of 1.0 cm with 0.7 -1.9 cm range. Under combined EMT-US guidance, nine out of 10 catheters passed through the tumour bed, yielding two rows of five catheters with more consistent spacing, with a mean spacing of 1.0 cm with 0.8-1.2 cm range. Conclusions: This phantom experiment suggests that combined EMT-US guidance can help achieve consistent catheter spacing over the tumour bed. These results are preliminary, and a trial of the method is now being conducted to validate our results. Additional research is being conducted to translate the proposed navigation technique to patient trials. Cough, dyspnea, chest pain and hemoptysis were assessed and graded by the primary medical team as absent (0), mild (1), moderate (2), significant (3), and severe (4) at the time of initial consult and in follow up. The duration of symptom improvement and re-expansion of the lung documented on imaging were analyzed using Kaplan-Meier curves. Results: Thirty-five patients with endobronchial metastasis were identified (14 GIT, five breast, three each of sarcoma, lymphoma, melanoma, renal cell, two head and neck, one cervix and one testicle). The majority of patients received three fractions of 700 cGy, and 15 patients had received EBRT to the lung beforehand and four afterwards. Median symptom-free survival was 67 days and overall survival was 117 days. Of patients reporting the presence of symptoms at baseline, improvement in cough was documented in 75.0 % (21/28), hemoptysis in 76.4% (13/18), pain in 64.3% (9/14) and dyspnea in 60.0% (18/30) for a median of three, three, three and six months respectively. Absent to mild cough (n = 8), hemoptysis (n = 17), pain (n = 21), and dyspnea (n = 6) scores were maintained for median periods of two, three and four months respectively. Of the 22 patients who had subsequent chest imaging, re-expansion was documented in 32%. There were no significant toxicities reported.
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Conclusions: Brachytherapy appears effective in achieving durable symptom control of cough hemoptysis and dyspnea in patients with metastatic disease located in the bronchus. It can be used in combination with or as an alternative to external beam radiotherapy, and should be considered routinely where available in this patient population. Further studies are required to better characterize expected symptom improvement and lung re-expansion rates. Results: Twenty-eight consecutively treated patients (17 male and 11 female) were identified for review. The average age at the time of treatment was 69.12 years. The majority of patients had a histopathological diagnosis of lung cancer (n = 21 non-small cell lung cancer, n = 1 small cell lung cancer) while the remainder (n = 6) had metastatic disease from other primaries. Fifteen patients had metastatic disease at presentation and nine were treated with systemic therapy prior to brachytherapy. The major indication for treatment included dyspnea (n = 18) and hemoptysis (n = 10) with 12 patients identified to have complete bronchial occlusion by bronchoscopy. Two patients were treated in a critical care setting and discharged home with stabilization of symptoms. The median overall survival for the group was 17.58 weeks while the median symptomatic progression-free survival was 9.82 weeks. Conclusions: Endobronchial HDR brachytherapy remains an efficacious treatment strategy for patients presenting with malignant bronchial occlusion causing dyspnea and/or hemoptysis. Our experience demonstrates that carefullyselected patients can experience effective palliation of symptoms despite an overall poor prognosis for the group. While limited, our experience also demonstrates that some patients with massive-hemoptysis or respiratory failure may benefit from treatment in the hands of a skilled brachytherapy team. Purpose: The dosimetry of trans-perineal interstitial brachytherapy (ISBT) treatment of gynecological malignancies can be significantly affected by the presence of rectal gas. This study evaluates the impact of using a rectal tube on dosimetric factors. Methods and Materials: Twenty-nine patients treated between August and December 2015 at our institution were included in a prospective registry trial. Data on the use of a rectal tube and dosimetric parameters were collected. Rectal volume, maximum dose to 2 cc of the rectum contour (D2cc) and the minimum dose to 90% of the high-risk clinical target volume (HR-CTV D90) was compared using a t-test for the rectal tube and no rectal tube cohorts. The rectal volume was measured from 1cm above and
